BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 23492556)

  • 1. Cyclophilin D as a potential target for antioxidants in neurodegeneration: the X-ALD case.
    López-Erauskin J; Ferrer I; Galea E; Pujol A
    Biol Chem; 2013 May; 394(5):621-9. PubMed ID: 23492556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidative stress underlying axonal degeneration in adrenoleukodystrophy: a paradigm for multifactorial neurodegenerative diseases?
    Galea E; Launay N; Portero-Otin M; Ruiz M; Pamplona R; Aubourg P; Ferrer I; Pujol A
    Biochim Biophys Acta; 2012 Sep; 1822(9):1475-88. PubMed ID: 22353463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidative stress modulates mitochondrial failure and cyclophilin D function in X-linked adrenoleukodystrophy.
    López-Erauskin J; Galino J; Bianchi P; Fourcade S; Andreu AL; Ferrer I; Muñoz-Pinedo C; Pujol A
    Brain; 2012 Dec; 135(Pt 12):3584-98. PubMed ID: 23250880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antioxidants halt axonal degeneration in a mouse model of X-adrenoleukodystrophy.
    López-Erauskin J; Fourcade S; Galino J; Ruiz M; Schlüter A; Naudi A; Jove M; Portero-Otin M; Pamplona R; Ferrer I; Pujol A
    Ann Neurol; 2011 Jul; 70(1):84-92. PubMed ID: 21786300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of Lorenzo's oil on oxidative stress in X-linked adrenoleukodystrophy.
    Deon M; Wajner M; Sirtori LR; Fitarelli D; Coelho DM; Sitta A; Barschak AG; Ferreira GC; Haeser A; Giugliani R; Vargas CR
    J Neurol Sci; 2006 Sep; 247(2):157-64. PubMed ID: 16750542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early oxidative damage underlying neurodegeneration in X-adrenoleukodystrophy.
    Fourcade S; López-Erauskin J; Galino J; Duval C; Naudi A; Jove M; Kemp S; Villarroya F; Ferrer I; Pamplona R; Portero-Otin M; Pujol A
    Hum Mol Genet; 2008 Jun; 17(12):1762-73. PubMed ID: 18344354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of pharmacological induction of fatty acid beta-oxidation in X-linked adrenoleukodystrophy.
    McGuinness MC; Zhang HP; Smith KD
    Mol Genet Metab; 2001; 74(1-2):256-63. PubMed ID: 11592822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxidative stress is induced in female carriers of X-linked adrenoleukodystrophy.
    Deon M; Sitta A; Barschak AG; Coelho DM; Terroso T; Schmitt GO; Wanderley HY; Jardim LB; Giugliani R; Wajner M; Vargas CR
    J Neurol Sci; 2008 Mar; 266(1-2):79-83. PubMed ID: 17915255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Valproic acid induces antioxidant effects in X-linked adrenoleukodystrophy.
    Fourcade S; Ruiz M; Guilera C; Hahnen E; Brichta L; Naudi A; Portero-Otín M; Dacremont G; Cartier N; Wanders R; Kemp S; Mandel JL; Wirth B; Pamplona R; Aubourg P; Pujol A
    Hum Mol Genet; 2010 May; 19(10):2005-14. PubMed ID: 20179078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrant regulation of the GSK-3β/NRF2 axis unveils a novel therapy for adrenoleukodystrophy.
    Ranea-Robles P; Launay N; Ruiz M; Calingasan NY; Dumont M; Naudí A; Portero-Otín M; Pamplona R; Ferrer I; Beal MF; Fourcade S; Pujol A
    EMBO Mol Med; 2018 Aug; 10(8):. PubMed ID: 29997171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondrial dysfunction and oxidative damage cooperatively fuel axonal degeneration in X-linked adrenoleukodystrophy.
    Fourcade S; López-Erauskin J; Ruiz M; Ferrer I; Pujol A
    Biochimie; 2014 Mar; 98():143-9. PubMed ID: 24076127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pioglitazone halts axonal degeneration in a mouse model of X-linked adrenoleukodystrophy.
    Morató L; Galino J; Ruiz M; Calingasan NY; Starkov AA; Dumont M; Naudí A; Martínez JJ; Aubourg P; Portero-Otín M; Pamplona R; Galea E; Beal MF; Ferrer I; Fourcade S; Pujol A
    Brain; 2013 Aug; 136(Pt 8):2432-43. PubMed ID: 23794606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel acyl-CoA synthetase in adrenoleukodystrophy target tissues.
    Moriya-Sato A; Hida A; Inagawa-Ogashiwa M; Wada MR; Sugiyama K; Shimizu J; Yabuki T; Seyama Y; Hashimoto N
    Biochem Biophys Res Commun; 2000 Dec; 279(1):62-8. PubMed ID: 11112418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elongation of very long-chain fatty acids is enhanced in X-linked adrenoleukodystrophy.
    Kemp S; Valianpour F; Denis S; Ofman R; Sanders RJ; Mooyer P; Barth PG; Wanders RJ
    Mol Genet Metab; 2005 Feb; 84(2):144-51. PubMed ID: 15670720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel Therapeutic Targets and Drug Candidates for Modifying Disease Progression in Adrenoleukodystrophy.
    Pujol A
    Endocr Dev; 2016; 30():147-60. PubMed ID: 26684655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tauroursodeoxycholic bile acid arrests axonal degeneration by inhibiting the unfolded protein response in X-linked adrenoleukodystrophy.
    Launay N; Ruiz M; Grau L; Ortega FJ; Ilieva EV; Martínez JJ; Galea E; Ferrer I; Knecht E; Pujol A; Fourcade S
    Acta Neuropathol; 2017 Feb; 133(2):283-301. PubMed ID: 28004277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The peroxisomal fatty acid transporter ABCD1/PMP-4 is required in the C. elegans hypodermis for axonal maintenance: A worm model for adrenoleukodystrophy.
    Coppa A; Guha S; Fourcade S; Parameswaran J; Ruiz M; Moser AB; Schlüter A; Murphy MP; Lizcano JM; Miranda-Vizuete A; Dalfó E; Pujol A
    Free Radic Biol Med; 2020 May; 152():797-809. PubMed ID: 32017990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidative damage compromises energy metabolism in the axonal degeneration mouse model of X-adrenoleukodystrophy.
    Galino J; Ruiz M; Fourcade S; Schlüter A; López-Erauskin J; Guilera C; Jove M; Naudi A; García-Arumí E; Andreu AL; Starkov AA; Pamplona R; Ferrer I; Portero-Otin M; Pujol A
    Antioxid Redox Signal; 2011 Oct; 15(8):2095-107. PubMed ID: 21453200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of sirtuin 1 as therapy for the peroxisomal disease adrenoleukodystrophy.
    Morató L; Ruiz M; Boada J; Calingasan NY; Galino J; Guilera C; Jové M; Naudí A; Ferrer I; Pamplona R; Serrano M; Portero-Otín M; Beal MF; Fourcade S; Pujol A
    Cell Death Differ; 2015 Nov; 22(11):1742-53. PubMed ID: 25822341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antioxidant protection: A promising therapeutic intervention in neurodegenerative disease.
    Ghosh N; Ghosh R; Mandal SC
    Free Radic Res; 2011 Aug; 45(8):888-905. PubMed ID: 21615270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.